ArticleCancer drug resistance (Alhambra, Calif.)2020

Quantitative analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRXL301, a nanoparticle of docetaxel.

Eiman Mukhtar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.